Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | Crizotinib | GDSC1000 | pan-cancer | AAC | -0.022 | 0.7 |
mRNA | CIL56 | CTRPv2 | pan-cancer | AAC | -0.019 | 0.7 |
mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | Compound 7d-cis | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | ML239 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | JW-55 | CTRPv2 | pan-cancer | AAC | -0.031 | 0.7 |
mRNA | FSC231 | CTRPv2 | pan-cancer | AAC | 0.032 | 0.7 |
mRNA | Bosutinib | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | ISOX | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |